Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Plos One
|
January 24, 2013
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
Caroline J Voskens, Simone M Goldinger, Carmen Loquai, et al.
Cancer Discovery
|
November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
Eliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
Nature Medicine
|
December 4, 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
Nature Medicine
|
June 21, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
Cancer Immunology Research
|
April 16, 2017
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
Paul C Tumeh, Matthew D Hellmann, Omid Hamid, et al.
The Lancet. Oncology
|
June 28, 2015
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas, Igor Puzanov, Reinhard Dummer, et al.
Nature Medicine
|
July 24, 2019
A case report of clonal EBV-like memory CD4<sup>+</sup> T cell activation in fatal checkpoint inhibitor-induced encephalitis
Douglas B Johnson, Wyatt J McDonnell, Paula I Gonzalez-Ericsson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2021
Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition
Sarah Knispel, Maximilian Gassenmaier, Alexander M Menzies, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Plos One
|
January 24, 2013
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
Caroline J Voskens, Simone M Goldinger, Carmen Loquai, et al.
Cancer Discovery
|
November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
Eliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
Nature Medicine
|
December 4, 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
Nature Medicine
|
June 21, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
Cancer Immunology Research
|
April 16, 2017
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
Paul C Tumeh, Matthew D Hellmann, Omid Hamid, et al.
The Lancet. Oncology
|
June 28, 2015
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas, Igor Puzanov, Reinhard Dummer, et al.
Nature Medicine
|
July 24, 2019
A case report of clonal EBV-like memory CD4<sup>+</sup> T cell activation in fatal checkpoint inhibitor-induced encephalitis
Douglas B Johnson, Wyatt J McDonnell, Paula I Gonzalez-Ericsson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 18, 2021
Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition
Sarah Knispel, Maximilian Gassenmaier, Alexander M Menzies, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
Page
of 7